SABS compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

SABSSAB Biotherapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

SABSSAB Biotherapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

SABSSAB Biotherapeutics, Inc.

3.05▼−4.09%

Mkt cap$283.9MRevenue$114,698Q4 FY24Revenue—

AMGNAmgen Inc

479.34▲+0.18%

Regular sessionNov 5 '26

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 5 '26

SABSSAB Biotherapeutics, Inc.

AMGNAmgen Inc

3.05▼−4.09%

Price

479.34▲+0.18%

$283.9M

Mkt cap

$258.8B

Q4 FY24$114,698

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

SABS3.05▼−4.09%vsAMGN479.34▲+0.18%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SABS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SABS 5

EBSEmergent BioSolutions Canadasupplier

—Avance Clinical PTY, Ltd ("Avance")unlistedsupplier

—Fortrea Holdings Inc. ("Fortrea")unlistedsupplier

—Sanford Applied Biosciencesunlistedsupplier

1 more · SABS chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

SABS, solidAMGN, dashed